Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.www.denalitherapeutics.com
1
MENTIONS
1
EPISODES
1
PODCASTS
Search complete. 1 mention across 1 episode found for "Denali Therapeutics Inc.".
Sep 15, 2026
Max BrennanHOST
Today, I'm joined by Tony Estrada, co-founder, president, and CEO of Tenvi Therapeutics.
Max BrennanHOST
Before founding Tenvi, Tony held leadership roles at both Genentech and Denali Therapeutics, where he led the discovery sciences organization and helped advance multiple programs across neurology, inflammation, and immunology.
Max BrennanHOST
Today, he's building Tenvi, a company developing precision-engineered small molecule therapies for neurological and peripheral diseases.
Max BrennanHOST
In this conversation, we discuss the, the journey to founding Tenvi, building a biotech in one of the toughest funding environments in recent years, why neuroscience is entering an exciting new era, the importance of mentorship, and where AI could transform the future of drug discovery.